Dermatology
Conference Coverage
PLA testing brings nuance to the diagnosis of early-stage melanoma
“Future prospective randomized clinical trials are needed to examine role of genetic expression profiling in staging and managing patients,” Dr....
Latest News
Study finds discrepancies in biopsy decisions, diagnoses based on skin type
Disparities in dermatologic care among Black patients, compared with White patients, have been well documented.
Conference Coverage
Apremilast has neutral effect on vascular inflammation in psoriasis study
“There has been a keen interest in understanding how psoriasis therapies impact cardiovascular risk.”
Conference Coverage
Photoprotection strategies for melasma are increasing
A guide to tinted sunscreens published in December 2021 recommended that consumers choose a product that contains iron oxides, is labeled as broad...
Latest News
Global melanoma incidence high and on the rise
The highest incidence and mortality rates of cutaneous melanoma are in wealthy nations, a new study shows.
Conference Coverage
For pemphigus, rituximab is first line, expert says
There are many advantages to suppressing disease activity “as soon as possible” after diagnosis, Dr. Erin Wei pointed out.
Conference Coverage
Dupilumab treats itch and clears lesions in prurigo nodularis patients
There are currently no Food and Drug Administration–approved systemic therapies for PN.
Conference Coverage
Skin reactions to first COVID-19 vaccine don’t justify forgoing second dose
“There are no serious adverse consequences from these cutaneous reactions,” said Dr. Esther Freeman.
From the Journals
Melanoma increasing, but is this overdiagnosis?
“Just like for other cancers ... there should be clear guidelines as to which populations to screen, as well as when to start and when to stop...
Conference Coverage
Cellulitis care costly from misdiagnosis, needless hospitalizations
“Cellulitis is misdiagnosed about one-third of the time, and that cost is very high,” reported Jennifer L. Adams, MD.
Conference Coverage
Global registry tracks COVID-19 outcomes in atopic dermatitis patients
Dupilumab monotherapy was associated with lower odds of hospitalizations compared with other therapies.